Abrexa Pharmaceuticals is a developer of drugs designed to treat Alzheimer disease.
Abrexa Pharmaceuticals has raised $23.0M in total funding. The most recent round was Series B. The last funding was announced in April 2025.
Abrexa Pharmaceuticals is headquartered in San Diego, United States.
Abrexa Pharmaceuticals is a developer of drugs designed to treat Alzheimer disease.
Abrexa Pharmaceuticals is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Abrexa Pharmaceuticals — Funding & Investors." VCBacked, April 24, 2025, https://www.vcbacked.co/company/abrexa-pharmaceuticals. Accessed August 14, 2026.
VCBacked. (2025). Abrexa Pharmaceuticals — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/abrexa-pharmaceuticals
{{cite web |title=Abrexa Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/abrexa-pharmaceuticals |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated